Japanese pharmaceutical firm Astellas Pharma has entered into a strategic partnership with ClearPath Development Company to form a portfolio of development companies focused on producing vaccines for infectious diseases.
7 January 2014
27 March 2013 Analysis
British scientists have developed a way to create an entirely synthetic vaccine, eliminating the need to rely on dangerous live infectious virus, making the process much safer.
12 February 2013
A specialised centre focusing on the development of drugs for infectious diseases commonly found in developing countries, such as tuberculosis (TB) and malaria, is to be set up by The...
12 September 2010
US biopharmaceutical firms currently have 395 drugs and vaccines to fight infectious diseases in clinical trials or under review by the US Food and Drug Administration, according to a report...